NCT06231407Completed
Increasing Medication Check Participation Through Applying CT-r
Recovery Oriented Cognitive Therapy (CT-R) Medication Checks: An Acceptability and Feasibility Trial, Standard Operating Procedure
Source: ClinicalTrials.gov · Last updated 30 Jan 2024
Brief summary (registry, in English)
The goal of this feasibility and acceptability trial is to learn about the acceptability of adding a recovery-oriented, psychological framework to a standard medication management appointment with a psychiatrist and any impact on attendance and functioning. The main question\[s\] it aims to answer are: 1. Will CT-R medication checks will be acceptable to the patient and feasible to deliver and receive, as measured by asking patients how they like the CT-R med checks and our ability to do this study in addition to number of patient drop-outs? 2. Will CT-R medication checks will be related to significantly greater engagement with treatment as measured by: lower no-show rates, greater self-reported working alliance, and better treatment adherence? 3. Will CT-R medication checks will be related to greater activity and increase in functioning as measured by: time use survey, GAF, skill use? 4. Will CT-R medication checks will be related to a trend in improved defeatist beliefs, negative symptoms, paranoia, and self-esteem? Researchers will compare the group assigned to the trial psychiatrists to a small group who were assigned to non-trial psychiatrists to see if the intervention impacted any of the above questions beyond TAU.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 26 (actual)
- First submitted
- 19 Jul 2023
- Start date
- 17 Mar 2022
- Primary completion date
- 13 Jun 2023
- Lead sponsor
- Vanderbilt University Medical Center
- Diseases
- Schizophrenia
- NCT number
- NCT06231407
What you commit to
- Study type: Interventional
- Participants enrolled: 26
- From 17 Mar 2022 to the primary completion date, 13 Jun 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Autism spectrum disorder
Other
- Significant intellectual disability
- Cannot read/write English
Who the study is looking for
- 18-80 years old
- Schizophrenia-spectrum disorder
- Typically scheduled 1x/month
- Willingness to complete 2-3 hours of testing at multiple timepoints
- Likely to stay in our clinic for the next 1-2 years
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt University Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.